Monograph: Addressing Challenges and Overcoming Barriers in the Care of Patients with Asthma
This activity outlines current asthma diagnostic guidelines, pharmacologic options, and effective strategies for follow-up care for asthma patients. Also available, Clinical Dialogue and eCase Challenge Addressing Challenges and Overcoming Barriers in the Care of Patients with Asthma.

Addressing Challenges and Overcoming Barriers in the Care of Patients with Asthma

Lawrence Herman, MPA, PA-C, DFAAPA; Susan Bose Stempek, MMSc, PA-C, FCCP; Christy P. Wilson, MPAS, PA-C

Asthma is a multifaceted disease that presents with a number of challenges for those who work with patients in primary care. Though multiple guidelines are available, many clinicians do not reference them because of their complexity and cumbersome nature. Ultimately, this may result in suboptimal care for patients and worse clinical outcomes. Given the high level of misdiagnosis with asthma, PAs should be aware of the current guideline recommendations for diagnosis, which include assessments of symptoms and spirometry testing. A correct diagnosis is essential for appropriate treatment selection and, similarly, appropriate treatment selection is essential for optimal clinical management of patients. PAs should review all approved therapies, with considerations placed on whether the selected treatment has been tailored to the needs and abilities of the patient. At every visit, PAs should take the opportunity to stress how to take medication correctly, including proper technique as well as the differences between use of controller and reliever therapies. PAs should also acknowledge poor treatment adherence among patients and implement collaborative care measures as necessary. Lastly, PAs should review how to assess asthma control and provide proper follow-up care. Together, these strategies will help to improve clinical outcomes and patient quality of life for those with asthma. 

Educational Objectives

At the conclusion of this activity, the PA should be better able to:
  • Outline the current asthma diagnostic guidelines and the role of spirometry in making accurate diagnoses.
  • Summarize the pharmacologic options for patients with asthma based on symptom severity.
  • Discuss asthma medications currently in development.
  • Identify the potential causes of nonadherence in patients with asthma.
  • Outline strategies to improve adherence to asthma therapies using patient-centered collaborative care.
  • Review current guidelines for the assessment of asthma control.
  • Identify effective strategies for follow-up care for asthma patients.

Accreditation Statement

This activity has been reviewed and is approved for a maximum of 1.50 AAPA Category 1 CME credit by the AAPA Review Panel. Participants should only claim credit commensurate with their participation in the CME activity. This program was planned in accordance with AAPA’s CME Standards for Enduring Material Programs and for Commercial Support of Enduring Material Programs. Approval is valid until February 28, 2019.

Responsibility Statement

AAPA takes responsibility for the content, quality, and scientific integrity of this CME activity.

Disclosure Policy Statement

It is the policy of AAPA to require the disclosure of the existence of any significant financial interest or any other relationship a faculty member has with the commercial interest of any commercial product discussed in an educational presentation. The participating faculty reported the following:

Faculty

Lawrence Herman, MPA, PA-C, DFAAPA
Moderator
Associate Program Director, Adjunct Professor
University of Texas Medical Branch - Galveston
PA Studies
Galveston, TX
Disclosures: Consultant - Novo Nordisk; Speaker’s Bureau - Novo Nordisk

Susan Bose Stempek, MMSc, PA-C, FCCP
Director of Advanced Practice
Medical ICU PA
Lahey Hospital and Medical Center
Burlington, MA
Disclosure: No relationship with any commercial interests whose products or services may be mentioned during this presentation.

Christy P. Wilson, MPAS, PA-C
Pulmonary and Sleep Medicine APP Director
Piedmont Pulmonary Division
Piedmont Physicians Georgia Lung Associates
Atlanta, GA

Disclosures: No relationship with any commercial interests whose products or services may be mentioned during this presentation.

Activity Planners

Michael Speidel, Jennifer Gregg, PhD, and Joanne Jeffers, Medical Logix, LLC have no relationship with any commercial interests whose products or services may be mentioned during this presentation.

AAPA Staff Activity Planners

Daniel Pace has no relationship with any commercial interests whose products or services may be mentioned during this presentation.

Off-Label/Unapproved Product(s) Discussion

Lawrence Herman: dupilumab, fevipiprant, lebrikizumab, tezepelumab

Disclaimer

The opinions and comments expressed by faculty and other experts, whose input is included in this program, are their own. This enduring material is produced for educational purposes only. Please review complete prescribing information of specific drugs mentioned in this program including indications, contraindications, warnings, and adverse effects and dosage before administering to patients.

Acknowledgement of Commercial Support

Supported by an independent educational grant from Novartis Pharmaceuticals Corporation.

AAPA offers no returns or refunds for online CME activities purchased through the AAPA store. All sales are final.


Type:     Internet Activity (Enduring Material)
720 Registered Users